A prospective study of a monophasic oral contraceptive containing 30 mcg ethinyl oestradiol and 150 mcg desogestrel (Marvelon).
D000152:Acne Vulgaris; D001208:Asia; D001210:Asia, Southeastern; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003872:Dermatitis; D017135:Desogestrel; D003906:Developing Countries; D004194:Disease; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D006285:Health Planning; D008296:Malaysia; D008599:Menstruation Disturbances; D011446:Prospective Studies; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004997:Ethinyl Estradiol; D017135:Desogestrel
Acne--prevention and control; Asia; Contraception; Contraceptive Agents, Estrogen--administraction and dosage; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods--administraction and dosage; Contraceptive Methods--side effects; Dermatitis; Desogestrel--administraction and dosage; Desogestrel--side effects; Developing Countries; Diseases; Ethinyl Estradiol--administraction and dosage; Ethinyl Estradiol--side effects; Family Planning; Family Planning Programs; Malaysia; Menstruation Disorders; Oral Contraceptives, Combined--administraction and dosage; Oral Contraceptives, Combined--side effects; Oral Contraceptives--administraction and dosage; Oral Contraceptives--side effects; Prospective Studies; Research Methodology; Southeastern Asia; Studies